SEC Form 4 · accession 0000899243-16-033800
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Nov 16, 2016
Accepted (ET)
Nov 17, 2016 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 16, 2016 | S | 23,766 | $3.52 | D | 71,428 | I | Langer Family Holdings, LLLP |
| Common Stock | holding | — | — | — | 43,595 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.
Remarks
Exhibit 24.1 - Power of Attorney